Small VCs in the EU
What contribution do smaller VC funds make and what challenges do they face. This is what Rainer Westermann, Chairman at LSAA, and…
The Life Sciences Acceleration Alliance e.V. (LSAA) is a coalition of venture capitalists, corporate leaders, and subject matter experts dedicated to strengthening life sciences innovation and development in the EU seeking to ensure that policy in Europe evolves towards medical discovery, commercialisation and the benefit to patients.
There is an opportunity for proactive policies that could better commercialise innovation and yield economic and health benefits
What contribution do smaller VC funds make and what challenges do they face. This is what Rainer Westermann, Chairman at LSAA, and…
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet…
Rainer Westermann, Chairman of LSAA, and Dr. Sascha Berger, General Partner at TVM Capital and LSAA board member discuss the importance of…
BIOTECH INFO - The flagship event of the European healthcare innovation ecosystem, organised in Paris with the support of major players in…
Rainer Westermann, Chairman of LSAA, Yann Le Flohic, Deputy Chairman of LSAA and John Standford, Executive Director of Incubate Coalition discuss the…
LABORJOURNAL - The life sciences in Germany and other European countries enjoy an excellent reputation, but too rarely do they give rise…
Rainer Westermann (LSSA Chairman) speaks with Barbara Diehl, CPO at SPRIND, and Dr. Klaus Stöckemann, Managing Partner at Peppermint Venture Partners and…
Yann Le Flohic from LSAA interviews Juliette Audet, partner at Forbion, on how VCs and private investors support HealthTech and participate in…
Here you can change your privacy preferences.